Curated News
By: NewsRamp Editorial Staff
October 10, 2024
Pharmagreen Biotech, Inc. Unveils Promising Revenue Projections for Live Rosin Development Project
Discuss on RedditTLDR
- Pharmagreen's Live Rosin project has the potential for high revenue, making it a lucrative investment opportunity.
- Pharmagreen's Live Rosin is a specialized form of cannabis oil, produced through a solventless extraction process, ensuring purity and potency.
- Pharmagreen's focus on innovative farming and processing models for Live Rosin contributes to the cannabis industry's quality and sustainability.
- Pharmagreen's Live Rosin sets new industry standards for quality and potency in cannabis concentrates.
Impact - Why it Matters
This news matters as it highlights the potential revenue and market impact of Pharmagreen's specialized cannabis oil development. The company's projected revenues and strategic market expansion plans could have significant implications for the cannabis industry and potential investors.
Summary
Pharmagreen Biotech, Inc. is developing a highly sought-after cannabis oil known as Live Rosin, which promises unmatched purity, potency, and flavor. The company's innovative farming and processing model is projected to yield impressive revenues, with potential gross revenues ranging from $19 million to a staggering $635 million within the first three years. To ensure successful distribution and market access for its premium Live Rosin, Pharmagreen is actively seeking distributors, joint venture partnerships, and exploring the acquisition of a cGMP-certified cannabis lab in Europe. This strategic move would enable Pharmagreen to tap into the lucrative EU cannabis market, where Live Rosin commands even higher prices.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Pharmagreen Biotech, Inc. Unveils Promising Revenue Projections for Live Rosin Development Project
